Shares of CPIX Up 19.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 23, 11:55AM CST
SmarTrend identified an Uptrend for Cumberland Pharmaceuticals (NASDAQ:CPIX) on August 6th, 2014 at $4.83. In approximately 5 months, Cumberland Pharmaceuticals has returned 19.17% as of today's recent price of $5.75.
CPIX: 6.05 (+0.33)
Why Cumberland Pharmaceuticals Is A Buy After Q3 Earnings
Daniel Ward - at Seeking Alpha - Thu Nov 06, 8:29AM CST
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals EPS of $0.04
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 11:47PM CST
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals' (CPIX) CEO J. Kazimi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 7:01PM CST
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results
PR Newswire - Tue Nov 04, 3:05PM CST
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2014 financial results.
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014
PR Newswire - Tue Oct 21, 3:05PM CDT
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release third quarter 2014 financial results after the market closes on Tuesday, November 4, 2014. A conference call and live Internet webcast will be held on Tuesday, November 4, 2014, at 4:30 p.m. Eastern Time to discuss the results.
CPIX: 6.05 (+0.33)
Caldolor® Safely Treats Fever In Hospitalized Children
PR Newswire - Tue Oct 14, 3:05PM CDT
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that treatment with intravenous ibuprofen was superior in reducing temperatures in hospitalized, febrile pediatric patients when compared to treatment with oral or suppository acetaminophen. These results were presented at the American Academy of Pediatrics National Conference & Exhibition in San Diego, California.
CPIX: 6.05 (+0.33)
Caldolor® Provides Favorable Inflammatory Response Results In Laparoscopic Cholecystectomy Surgery Patients
PR Newswire - Fri Oct 10, 2:11PM CDT
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana.
CPIX: 6.05 (+0.33)
IEI, PSDV, DTT, CPIX, ERII, FLM Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 23, 3:29AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Imperial Equities Inc (NYSE:IEI), pSivida Corp (NASDAQ
IEI: 121.75 (-0.13), FLM: 45.26 (-0.02), PSDV: 4.00 (-0.03), DB: 30.95 (+0.04), CPIX: 6.05 (+0.33), DTT: 25.41 (unch), IEI.VN: 4.600 (-0.390), ERII: 5.06 (-0.03)
Global N-acetylcysteine Market Report 2014-2019
M2 - Tue Sep 16, 9:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f6gj3d/global) has announced the addition of the "Global N-acetylcysteine Industry Report 2014" report to their offering. The Global N-acetylcysteine Industry Report 2014 is a professional and in-depth study on the current state of the global N-acetylcysteine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The N-acetylcysteine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. N-acetylcysteine industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on twenty industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The N-acetylcysteine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - N-acetylcysteine Industry Overview - Global N-acetylcysteine Market Status Analysis - Major Regions N-acetylcysteine Market Status Analysis - Major Countries N-acetylcysteine Market Status and Analysis - Major Companies N-acetylcysteine Market Status and Analysis - N-acetylcysteine Industry Chain and Marketing Channels Analysis - N-acetylcysteine Industry Segment Market Analysis - N-acetylcysteine Industry Development Trend - N-acetylcysteine New Project Investment Feasibility Analysis - Global N-acetylcysteine Industry Research Conclusions Companies Mentioned - BASF - Bioniche Life Sciences - Cumberland Pharmaceuticals - Donboo Amino Acid - Hubei Jusheng Technology - Hubei Shengbaolai Biological Technology - Manus Aktteva Biopharma Llp - Ningbo Create-Bio Engineering - Ningbo Zhenhai Haide Amino Acid - Swacker Ag - Wuxi Enovo Chemical - Wuhan Grand Hoyo - Wuhan Hezhong Bio-Chemical - Wuhan Lullaby Pharmaceutical Chemical - Xys - Xinyi Hanling Biological Engineering - Zambon - Zhangjiagang Specom Biochemical - Zhangjiagang Huachang Pharmaceutical - Zhangjiagang Shuguang Biological For more information visit http://www.researchandmarkets.com/research/f6gj3d/global
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
PR Newswire - Tue Aug 05, 3:05PM CDT
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced second quarter 2014 financial results.
CPIX: 6.05 (+0.33)
Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014
PR Newswire - Tue Jul 22, 3:05PM CDT
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2014 financial results after the market closes on Tuesday, August 5, 2014. A conference call and live Internet webcast will be held on Tuesday, August 5, 2014, at 4:30 p.m. Eastern Time to discuss the results.
CPIX: 6.05 (+0.33)
Buffalo Announces LinkStation 200 Series of Easy To Use Network Attached Storage
PR Newswire - Tue Jan 07, 10:51AM CST
CONSUMER ELECTRONICS SHOW (CES) -- Buffalo Americas, a global leader in the design, development and manufacturing of wired and wireless networking and network and direct attached storage solutions, today announced its LinkStation(TM) 200 Series of easy to use network storage devices. Ideal for home users, the new LinkStation 200 Series provides simple network storage and backup and offers an assortment of features, allowing users to store, organize, access and stream media files from any computer, smartphone or tablet. Users can even set up a free personal cloud for access anytime, anywhere, at home or on the go.
PRGO: 166.11 (+1.96), CPIX: 6.05 (+0.33)